TerminatedNCT00637494
Mifepristone for depression
This study was terminated in the United States. It is testing mifepristone for depression.
Multiple locations, including Little RockDepression, SchizophreniaBehavioralOver 22 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT05953740
MK-5720 in people with Schizophrenia (MK-5720-001)
This study is completed in the United States. It is testing MK-5720 for schizophrenia.
Multiple locations, including GlendaleSchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Enrolling By InvitationNCT07455370
Moral Distress, Moral Injury and Post-Traumatic Stress for Nurses
This study is enrolling by invitation in the United States. It is testing Moral Distress, Moral Injury and Post-Traumatic Stress for PTSD.
Multiple locations, including PhoenixPTSDOther
TerminatedNCT03044249
MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
This study was terminated in the United States and in Canada. It is testing MP-101 for Schizophrenia.
Multiple locations, including PhoenixSchizophreniaDrugOver 50 Years
WithdrawnNCT04964843
NAC for AUD
This study was withdrawn. It is testing NAC for Addiction.
Location not clearly listedAddictionBehavioralFrom 18 Years to 74 Years
CompletedNCT01174355
ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
This study is completed in Israel. It is testing ND0801 for ADHD.
Multiple locations, including HaifaADHDDrugFrom 18 Years to 55 Years
CompletedNCT04106739
New Treatment for Addiction
This study is completed in India. It is testing new Treatment for Addiction.
In BengaluruAddictionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 50 Years
CompletedNCT00970281
Olanzapine in people with Schizophrenia
This study is completed in Japan. It is testing olanzapine for schizophrenia.
Multiple locations, including AichiSchizophreniaDrugFrom 20 Years to 64 Years
CompletedNCT06792136
ONO-1110 in people with Major Depressive Disorder
This study is completed in Japan. It is testing ONO-1110 for depression.
Multiple locations, including FukuokaDepressionDrugFrom 18 Years to 65 Years
CompletedNCT06805565
ONO-1110 in people with Social Anxiety Disorder
This study is completed in Japan. It is testing ONO-1110 for anxiety.
Multiple locations, including FukuokaAnxietyDrugFrom 18 Years to 65 Years
CompletedNCT05029401
Oral Ibogaine in Opioid Withdrawal
This study is completed in the United Kingdom. It is testing ibogaine for Addiction.
Multiple locations, including ManchesterAddictionDrugFrom 18 Years to 55 Years
CompletedNCT04451187
Seltorexant for depression
This study is completed in Belgium and in Germany. It is testing seltorexant for depression.
Multiple locations, including AlkenDepressionDrugFrom 21 Years to 80 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.